TR200402275T2 - Nörotik düzensizliklerin tedavisi - Google Patents
Nörotik düzensizliklerin tedavisiInfo
- Publication number
- TR200402275T2 TR200402275T2 TR2004/02275T TR200402275T TR200402275T2 TR 200402275 T2 TR200402275 T2 TR 200402275T2 TR 2004/02275 T TR2004/02275 T TR 2004/02275T TR 200402275 T TR200402275 T TR 200402275T TR 200402275 T2 TR200402275 T2 TR 200402275T2
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- neurotic disorders
- irregularity
- escitalopramine
- citalopramine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Eskitalopramin (sitalopramin S-(+)-enantiomeri) ya da bunun farmasotik olarak kabul edilebilir bir tuzunun aralarinda angziyete durumlari, özellikle genellestirilmis angziyete düzensizligi ve sosyal angziyete düzensizligi, travma sonrasi stres düzensizligi, obsesif kompülsif düzensizlik ve panik ataklarin bululndugu nörotik düzensizliklerin tedavisinde kullanisli bir ilacin hazirlanmasi için kullanimi.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900991 | 1999-07-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200402275T2 true TR200402275T2 (tr) | 2005-03-21 |
Family
ID=8099796
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00014T TR200200014T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi. |
TR2004/02277T TR200402277T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
TR2004/02275T TR200402275T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
TR2004/02276T TR200402276T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2002/00014T TR200200014T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi. |
TR2004/02277T TR200402277T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2004/02276T TR200402276T2 (tr) | 1999-07-08 | 2000-07-07 | Nörotik düzensizliklerin tedavisi |
Country Status (38)
Country | Link |
---|---|
US (6) | US7271194B2 (tr) |
EP (4) | EP1440690A3 (tr) |
JP (1) | JP4773011B2 (tr) |
KR (1) | KR100604176B1 (tr) |
CN (1) | CN1198610C (tr) |
AR (1) | AR021155A1 (tr) |
AT (1) | ATE339955T1 (tr) |
AU (6) | AU782514B2 (tr) |
BG (4) | BG110467A (tr) |
BR (1) | BR0011578A (tr) |
CA (4) | CA2687394A1 (tr) |
CL (3) | CL2008003938A1 (tr) |
CO (1) | CO5190674A1 (tr) |
CY (1) | CY1105806T1 (tr) |
CZ (1) | CZ200270A3 (tr) |
DE (1) | DE60030861T2 (tr) |
DK (1) | DK1200081T3 (tr) |
EA (1) | EA006555B1 (tr) |
ES (1) | ES2272298T3 (tr) |
HK (1) | HK1048069B (tr) |
HR (1) | HRP20010820A2 (tr) |
HU (1) | HUP0201791A3 (tr) |
IL (5) | IL146131A0 (tr) |
IS (1) | IS6137A (tr) |
ME (2) | ME00032B (tr) |
MX (1) | MXPA01011626A (tr) |
MY (1) | MY143278A (tr) |
NO (4) | NO329021B1 (tr) |
PL (1) | PL352030A1 (tr) |
PT (1) | PT1200081E (tr) |
SI (1) | SI1200081T1 (tr) |
SK (1) | SK82002A3 (tr) |
TR (4) | TR200200014T2 (tr) |
TW (1) | TWI232101B (tr) |
UA (1) | UA77645C2 (tr) |
WO (1) | WO2001003694A1 (tr) |
YU (1) | YU78701A (tr) |
ZA (1) | ZA200108856B (tr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR021155A1 (es) | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
GB0005477D0 (en) | 2000-03-07 | 2000-04-26 | Resolution Chemicals Limited | Process for the preparation of citalopram |
PT1301502E (pt) * | 2000-07-21 | 2005-09-30 | Lundbeck & Co As H | Compostos e sua utilizacao como inibidores do transporte de glicina |
CZ20033267A3 (en) * | 2001-05-01 | 2004-06-16 | H. Lundbeck A/S | The use of enantiomeric pure escitalopram |
DK1414435T3 (da) | 2001-07-31 | 2005-05-09 | Lundbeck & Co As H | Krystallinsk komposition indeholdende escitalopram |
WO2004004721A1 (en) * | 2002-07-08 | 2004-01-15 | University Of Florida | Use of ssri inhibitors to prevent or ameliorate trauma-related psychological disorders |
US20050137255A1 (en) * | 2002-12-23 | 2005-06-23 | H. Lundbeck A/S | Crystalline escitalopram hydrobromide and methods for preparing the same |
KR20050086933A (ko) * | 2002-12-23 | 2005-08-30 | 하. 룬트벡 아크티에 셀스카브 | 브롬화수소산에스시탈로프람 및 이의 제조방법 |
US20050154052A1 (en) * | 2003-03-24 | 2005-07-14 | Hetero Drugs Limited | Novel crystalline forms of (s)-citalopram oxalate |
US20090093461A1 (en) * | 2003-07-02 | 2009-04-09 | Astrazeneca Ab | Methods of Treating Anxiety and Mood Disorders |
EP2272514A1 (en) * | 2003-12-02 | 2011-01-12 | PharmaNeuroBoost N.V. | Use of low dose pipamperone and a second active compound in the treatment of neurodegenerative diseases |
US7884096B2 (en) * | 2003-12-02 | 2011-02-08 | Pharmaneuroboost N.V. | Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
US7855195B2 (en) * | 2003-12-02 | 2010-12-21 | Pharmaneuroboost N.V. | Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
EP1954257A4 (en) | 2005-10-14 | 2009-05-20 | Lundbeck & Co As H | METHOD FOR TREATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM WITH A LOW-DOSED COMBINATION OF ESCITALOPRAM AND BUPROPION |
US20070134322A1 (en) * | 2005-12-14 | 2007-06-14 | Forest Laboratories, Inc. | Modified and pulsatile release pharmaceutical formulations of escitalopram |
FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
TW200817003A (en) * | 2006-07-31 | 2008-04-16 | Sanofi Aventis | Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1143703A (tr) | 1965-03-18 | |||
GB1526331A (en) | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
US4439545A (en) | 1981-11-19 | 1984-03-27 | Societe D "Expansion Scientifique "Expansia" | Acrylic copolymers of N-acryloylpolymethyleneimines or N-acryloyldialkylamides, N,N'-acryloyldiaminoalcanes and N-acryloylaminoacids (or esters) their preparation and use as cation exchangers |
GB8419963D0 (en) | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
GB8607313D0 (en) * | 1986-03-25 | 1986-04-30 | Ici Plc | Pharmaceutical compositions |
GB8814057D0 (en) * | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
US4902710A (en) | 1988-12-14 | 1990-02-20 | Eli Lilly And Company | Serotonin and norepinephrine uptake inhibitors |
US5114976A (en) * | 1989-01-06 | 1992-05-19 | Norden Michael J | Method for treating certain psychiatric disorders and certain psychiatric symptoms |
US4962128A (en) | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
DK213290D0 (da) * | 1990-09-06 | 1990-09-06 | Lundbeck & Co As H | Treatment of cerebrovascular disorders |
US5296507A (en) * | 1990-09-06 | 1994-03-22 | H.Lundbeck A/S | Treatment of cerbrovascular disorders |
US5708035A (en) | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
WO1992018005A1 (en) | 1991-04-16 | 1992-10-29 | National Institutes Of Health | Method of treating trichotillomania and onychophagia |
DK0612242T3 (da) | 1991-11-15 | 2003-10-20 | Sepracor Inc | Anvendelse af ren S(+)-isomer af fluoxetin til fremstilling af et medikament mod migræne |
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug responses by serotonin 1A receptor antagonists |
US5627196A (en) * | 1995-01-17 | 1997-05-06 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
AU4918796A (en) * | 1995-02-10 | 1996-08-27 | Eli Lilly And Company | Methods of treating or preventing psychiatric disorders |
US5554383A (en) | 1995-04-06 | 1996-09-10 | Trustees Of Tufts College | Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression |
SE9501567D0 (sv) | 1995-04-27 | 1995-04-27 | Astra Ab | A new combination |
EP0759299B1 (en) | 1995-08-16 | 2000-04-26 | Eli Lilly And Company | Potentiation of serotonin response |
US5846982A (en) * | 1996-06-14 | 1998-12-08 | Eli Lilly And Company | Inhibition of serotonin reuptake |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5747494A (en) * | 1996-06-28 | 1998-05-05 | U C B S.A. | Pharmaceutical compositions for the treatment of depressive disorders |
US5958429A (en) | 1996-08-16 | 1999-09-28 | Eli Lilly And Company | Potentiation of serotonin response |
ZA977967B (en) | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
US5776969A (en) * | 1997-02-27 | 1998-07-07 | Eli Lilly And Company | Treatment of sleep disorders |
US6069177A (en) | 1997-07-08 | 2000-05-30 | The Hong Kong University Of Science And Technology | 3-Hydroxy-propanamine derived neuronal reuptake inhibitors |
SE9703379D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | New compounds |
SE9703375D0 (sv) | 1997-09-18 | 1997-09-18 | Astra Ab | A new combination |
CN1286687A (zh) * | 1997-11-11 | 2001-03-07 | H·隆德贝克有限公司 | 制备西酞普兰的方法 |
ATE228119T1 (de) * | 1998-04-15 | 2002-12-15 | Pfizer Prod Inc | Heterocyclische carboxamide |
EP1100501A4 (en) * | 1998-06-30 | 2002-12-04 | Lilly Co Eli | PYRROLIDINE AND PYRROLIDINE DERIVATIVES INFLUENTING THE SYSTEMS ASSOCIATED WITH SEROTONIN |
DE69935331T2 (de) | 1998-07-13 | 2007-10-31 | NPS Pharmaceuticals, Inc., Salt Lake City | Verfahren und verbindungen zur behandlung der depression |
JP2002520353A (ja) | 1998-07-16 | 2002-07-09 | マサチューセッツ インスティテュート オブ テクノロジー | ストレスの処置のための組成物 |
US6579899B1 (en) | 1998-07-16 | 2003-06-17 | Massachusetts Institute Of Technology | Composition for treatment of stress |
US6150376A (en) * | 1998-08-05 | 2000-11-21 | Georgetown University | Bi- and tri-cyclic aza compounds and their uses |
SE9803157D0 (sv) | 1998-09-16 | 1998-09-16 | Astra Ab | A new composition |
SE9803158D0 (sv) * | 1998-09-16 | 1998-09-16 | Astra Ab | A new composition |
DE69904853T2 (de) * | 1998-10-20 | 2003-09-04 | Lundbeck As Valby H | Verfahren zur herstellung von citalopram |
AR021509A1 (es) * | 1998-12-08 | 2002-07-24 | Lundbeck & Co As H | Derivados de benzofurano, su preparacion y uso |
NZ514671A (en) * | 1999-04-14 | 2003-10-31 | H | Method for the preparation of citalopram |
AR021155A1 (es) * | 1999-07-08 | 2002-06-12 | Lundbeck & Co As H | Tratamiento de desordenes neuroticos |
US6333357B1 (en) | 1999-11-05 | 2001-12-25 | Be Able, Llc | Behavior chemotherapy |
UA77650C2 (en) | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
GB2357762B (en) * | 2000-03-13 | 2002-01-30 | Lundbeck & Co As H | Crystalline base of citalopram |
AU5565401A (en) | 2000-04-24 | 2001-11-07 | Aryx Therapeutics | Materials and methods for the treatment of depression |
JP2002361405A (ja) * | 2000-09-25 | 2002-12-18 | Showa Denko Kk | 熱交換器の製造方法 |
CZ20033267A3 (en) * | 2001-05-01 | 2004-06-16 | H. Lundbeck A/S | The use of enantiomeric pure escitalopram |
-
2000
- 2000-07-06 AR ARP000103442A patent/AR021155A1/es unknown
- 2000-07-07 CA CA2687394A patent/CA2687394A1/en not_active Abandoned
- 2000-07-07 AU AU58061/00A patent/AU782514B2/en not_active Expired
- 2000-07-07 MX MXPA01011626A patent/MXPA01011626A/es not_active Application Discontinuation
- 2000-07-07 YU YU78701A patent/YU78701A/sh unknown
- 2000-07-07 HU HU0201791A patent/HUP0201791A3/hu unknown
- 2000-07-07 UA UA2001128286A patent/UA77645C2/uk unknown
- 2000-07-07 TR TR2002/00014T patent/TR200200014T2/tr unknown
- 2000-07-07 EP EP04007521A patent/EP1440690A3/en not_active Withdrawn
- 2000-07-07 TR TR2004/02277T patent/TR200402277T2/tr unknown
- 2000-07-07 MY MYPI20003122A patent/MY143278A/en unknown
- 2000-07-07 EP EP04007522A patent/EP1440691A3/en not_active Withdrawn
- 2000-07-07 CO CO00051031A patent/CO5190674A1/es not_active Application Discontinuation
- 2000-07-07 CA CA002373757A patent/CA2373757C/en not_active Expired - Lifetime
- 2000-07-07 CA CA2687396A patent/CA2687396A1/en not_active Abandoned
- 2000-07-07 ES ES00943692T patent/ES2272298T3/es not_active Expired - Lifetime
- 2000-07-07 SK SK8-2002A patent/SK82002A3/sk not_active Application Discontinuation
- 2000-07-07 KR KR1020017016006A patent/KR100604176B1/ko not_active IP Right Cessation
- 2000-07-07 IL IL14613100A patent/IL146131A0/xx unknown
- 2000-07-07 EP EP04007520A patent/EP1440689A3/en not_active Withdrawn
- 2000-07-07 EP EP00943692A patent/EP1200081B1/en not_active Revoked
- 2000-07-07 PT PT00943692T patent/PT1200081E/pt unknown
- 2000-07-07 ME MEP-2008-25A patent/ME00032B/me unknown
- 2000-07-07 TR TR2004/02275T patent/TR200402275T2/tr unknown
- 2000-07-07 ME MEP-25/08A patent/MEP2508A/xx unknown
- 2000-07-07 JP JP2001508974A patent/JP4773011B2/ja not_active Expired - Lifetime
- 2000-07-07 AT AT00943692T patent/ATE339955T1/de active
- 2000-07-07 PL PL00352030A patent/PL352030A1/xx not_active Application Discontinuation
- 2000-07-07 CA CA2687392A patent/CA2687392A1/en not_active Abandoned
- 2000-07-07 TR TR2004/02276T patent/TR200402276T2/tr unknown
- 2000-07-07 DE DE60030861T patent/DE60030861T2/de not_active Expired - Lifetime
- 2000-07-07 CN CNB008100292A patent/CN1198610C/zh not_active Expired - Lifetime
- 2000-07-07 CZ CZ200270A patent/CZ200270A3/cs unknown
- 2000-07-07 WO PCT/DK2000/000377 patent/WO2001003694A1/en active Application Filing
- 2000-07-07 BR BR0011578-9A patent/BR0011578A/pt active Search and Examination
- 2000-07-07 DK DK00943692T patent/DK1200081T3/da active
- 2000-07-07 SI SI200030910T patent/SI1200081T1/sl unknown
- 2000-07-07 EA EA200200137A patent/EA006555B1/ru not_active IP Right Cessation
- 2000-07-28 TW TW089115110A patent/TWI232101B/zh not_active IP Right Cessation
-
2001
- 2001-10-23 IL IL146131A patent/IL146131A/en active IP Right Grant
- 2001-10-26 ZA ZA200108856A patent/ZA200108856B/xx unknown
- 2001-10-30 IS IS6137A patent/IS6137A/is unknown
- 2001-11-06 HR HR20010820A patent/HRP20010820A2/hr not_active Application Discontinuation
- 2001-12-12 US US10/021,126 patent/US7271194B2/en not_active Expired - Lifetime
-
2002
- 2002-01-04 BG BG11046709A patent/BG110467A/bg unknown
- 2002-01-04 BG BG106279A patent/BG106279A/bg unknown
- 2002-01-04 BG BG11046809A patent/BG110468A/bg unknown
- 2002-01-04 BG BG11046609A patent/BG110466A/bg unknown
- 2002-01-07 NO NO20020062A patent/NO329021B1/no not_active IP Right Cessation
-
2003
- 2003-01-09 HK HK03100231.6A patent/HK1048069B/zh not_active IP Right Cessation
- 2003-08-07 US US10/637,822 patent/US20040029958A1/en not_active Abandoned
- 2003-08-07 US US10/637,820 patent/US7265151B2/en not_active Expired - Lifetime
- 2003-08-07 US US10/637,821 patent/US20040029957A1/en not_active Abandoned
- 2003-08-20 US US10/644,143 patent/US6960613B2/en not_active Expired - Lifetime
-
2005
- 2005-06-20 AU AU2005202686A patent/AU2005202686B2/en not_active Expired
- 2005-06-20 AU AU2005202684A patent/AU2005202684B2/en not_active Ceased
- 2005-06-20 AU AU2005202685A patent/AU2005202685B2/en not_active Ceased
- 2005-08-09 IL IL170192A patent/IL170192A/en unknown
- 2005-08-09 IL IL170194A patent/IL170194A/en unknown
- 2005-08-09 IL IL170193A patent/IL170193A/en unknown
-
2006
- 2006-11-27 CY CY20061101706T patent/CY1105806T1/el unknown
-
2007
- 2007-08-10 US US11/837,317 patent/US20070276035A1/en not_active Abandoned
-
2008
- 2008-12-24 AU AU2008264188A patent/AU2008264188A1/en not_active Withdrawn
- 2008-12-24 AU AU2008264182A patent/AU2008264182A1/en not_active Withdrawn
- 2008-12-30 CL CL2008003938A patent/CL2008003938A1/es unknown
- 2008-12-30 CL CL2008003939A patent/CL2008003939A1/es unknown
- 2008-12-30 CL CL2008003941A patent/CL2008003941A1/es unknown
-
2010
- 2010-03-10 NO NO20100334A patent/NO20100334L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100333A patent/NO20100333L/no not_active Application Discontinuation
- 2010-03-10 NO NO20100335A patent/NO20100335L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200402275T2 (tr) | Nörotik düzensizliklerin tedavisi | |
MXPA03003960A (es) | Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos. | |
RS50876B (sr) | Upotreba flibanserina u lečenju seksualnih poremećaja | |
CY1112184T1 (el) | Πυριδοξαμινη για χρηση στην αγωγη της διαβητικης nεφροπαθειας στο διαβητη τυπου ii | |
AR034213A1 (es) | Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv | |
TR200000755T2 (tr) | Karşıt olma-karşı gelme bozukluğunun tedavisi. | |
CY1109238T1 (el) | Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη | |
NO20063308L (no) | Kombinasjon av flupirtin og tramadol | |
BRPI0411176A (pt) | combinação farmacêutica consistindo de modafinil e outra droga | |
SE0102147D0 (sv) | New methods | |
BR0210650A (pt) | Tablete, e, uso do mesmo | |
HUP0402619A2 (hu) | Norepinefrin re-uptake inhibitorok alkalmazása a megértési nehézségek kezelésére használható gyógyszer előállítására | |
AR023597A1 (es) | Utilizacion del saredutant y de sus sales farmaceuticamente aceptables para la preparacion de medicamentos utiles en el tratamiento o la prevencion delconjunto de los trastornos del humor, de los trastornos de adaptacion o de los trastornos mixtos ansiedad-depresion | |
MXPA04001912A (es) | Aminobenzofenonas novedosas. | |
DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
BR0214060A (pt) | Uso de monoidroxicarbamazepina em distúrbio afetivo e de atenção e dor neuropática | |
BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението | |
UY26990A1 (es) | Nuevas composiciones de medicamentos | |
DE50005714D1 (de) | Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl | |
SE0300535D0 (sv) | Treatment of burns | |
WO2005020976A3 (en) | Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors | |
BG108033A (en) | Use of 2-amino-1-(4-hydroxy-2-methane sulphonamidophenyl)ethanol for treating urinary incontinence. | |
UA3958U (uk) | Спосіб лікування хронічного гастродуоденіту з супутнім хронічним холециститом |